Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profiling.

Scientific reports - 5 Apr 2023

Ledesma Martín, Poodts Daniela, Amoia Sofía, Hajos Silvia, Fundia Ariela, Vay Carlos, Pibuel Matías, Lompardía Silvina

Abstract excerpt

Chemotherapy mistreatment is partially due to a lack of rapid and reliable tools to discriminate between sensitive and resistant phenotypes. In many cases, the resistance mechanism is not fully understood, contributing to the diagnostic tools' absence. This work aims to determine the capacity of MALDI-TOF-MS profiling to discriminate between chemotherapy-resistant and sensitive phenotypes in leukemia and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Glioblastoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia

Share to Phenotype

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Source

Open in PubMed Open full text

Identifiers

PMID: 37019937
DOI: 10.1038/s41598-023-32608-2
PMCID: PMC10076308

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profiling.PMID 37019937Read ↗

Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profilingSemantic proximity Read ↗

Multi-Omics Analyses Reveal Mitochondrial Dysfunction Contributing to Temozolomide Resistance in Glioblastoma CellsSemantic proximity Read ↗

Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challengesSemantic proximity Read ↗

Integrative Machine Learning Framework for Detecting Resistance-Associated Mutations in Cancer Cell LinesSemantic proximity Read ↗

Integrative Machine Learning Framework for Detecting Resistance-Associated Mutations in Cancer Cell LinesSemantic proximity Read ↗

New Insights into Neuroblastoma Cisplatin Resistance: A Comparative Proteomic and Meta-Mining InvestigationSemantic proximity Read ↗

Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancerSemantic proximity Read ↗

DIA-based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid LeukemiaSemantic proximity Read ↗

Identification of chemoresistance-related cell-surface glycoproteins in leukemia cells and functional validation of candidate glycoproteins.Semantic proximity Read ↗

Proteomic and metabolomic exploration in relapse acute myeloid leukemia bone marrow supernatant combined with genetic characteristics.Semantic proximity Read ↗

Multi-omic profiling of tyrosine kinase inhibitor-resistant K562 cells suggests metabolic reprogramming to promote cell survivalSemantic proximity Read ↗

Cell-Main Spectra Profile Screening Technique in Simulation of Circulating Tumour Cells Using MALDI-TOF Mass SpectrometrySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.